Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Grown Rogue International Inc. (GRUSF)
USD0.45
-0.01 (-1.17%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
550 Airport Road 97504
Medford, OR, US
Medford, OR, US
CEO
J. Obie Strickler
Website
grownrogue.com
IPO
2010-10-15
CIK 1463000 ISIN CA39986R3045
Also trades on
Canadian Securities Exchange · GRIN.CN (CAD)
Other OTC · GRUSF (USD)
Description
Grown Rogue International Inc., operating through its subsidiary entities, focuses on the cultivation and retail of cannabis products across the United States. Its diverse product portfolio includes a variety of cannabis flower, such as indica, sativa, and hybrid strains, alongside edibles, vaporization cartridges, pre-rolled joints, and concentrated cannabis forms. The company's merchandise is distributed and sold primarily through licensed dispensaries. Grown Rogue International Inc.'s corporate headquarters are located in Medford, Oregon.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.45
-0.01 (-1.17%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
249.2K
Beta
-1.03
Float Shares
154.07M
Free Float %
61.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.65% | -6.40% | +28.57% | -2.70% | +2.86% | -30.22% | -11.98% | +166.67% | +167.46% | -85.64% | -98.42% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.45
DCF (Levered)
0.39
-13.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.09
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
2 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-18.0% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+153.8% ★ Q1'26: -100.0% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+7.0% ★
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+15.3% ★
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+8.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+7.6% Q1'26: -100.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×3.89×
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Sep 2024 actual |
|---|---|---|---|---|---|---|
| Revenue |
3.92M
est: 9.20M (-57.3%)
|
4.24M
est: 4.01M (+5.9%)
|
9.38M
est: 11.83M (-20.7%)
|
17.76M
est: 23.11M (-23.2%)
|
21.83M
est: 27.09M (-19.4%)
|
27.02M
est: 31.97M (-15.5%)
|
| EBITDA |
-3.86M
est: 831.2K (-564.4%)
|
-701.4K
est: 361.8K (-293.9%)
|
2.55M
est: 1.07M (+139.0%)
|
3.41M
est: 2.09M (+63.5%)
|
1.67M
est: 2.45M (-31.8%)
|
2.06M
est: 5.24M (-60.7%)
|
| EBIT |
-9.08M
est: 1.6K (-551,630.4%)
|
-1.50M
est: 716.00 (-209,294.8%)
|
283.2K
est: 2.1K (+13,285.6%)
|
1.56M
est: 4.1K (+37,601.4%)
|
1.11M
est: 4.8K (+22,708.0%)
|
1.12M
est: 3.24M (-65.5%)
|
| Net Income |
-9.72M
|
-3.15M
est: -7.01M (+55.0%)
|
-1.01M
est: 2.40M (-142.2%)
|
447.5K
est: 6.56M (-93.2%)
|
-518.0K
|
-11.30M
|
| SGA |
4.58M
est: 4.11M (+11.7%)
|
2.53M
est: 1.79M (+41.8%)
|
4.26M
est: 5.28M (-19.2%)
|
5.92M
est: 10.31M (-42.6%)
|
9.25M
est: 12.09M (-23.5%)
|
11.38M
est: 13.99M (-18.6%)
|
| EPS |
-0.14
|
-0.03
est: -0.03 (-17.8%)
|
-0.01
est: 0.01 (-174.1%)
|
0.00
est: 0.03 (-90.6%)
|
0.00
|
-0.05
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.37M
OE per share TTM
0.01
Owner's Yield
1.48%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
45.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
15
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Jesse Strickler | 36.29M | 21.00% | 36.29M | — | 36.29M | — | IN | USA | 2023-01-13 | ↗ |
| 2 | Gottbetter Capital Group, Inc. | 21.73M | 9.00% | 2.17M | — | — | — | CO | Delaware | 2010-07-01 | ↗ |
| 3 | Aaron Edelheit | 14.81M | 8.68% | 14.81M | — | 14.81M | — | IN | United States of America | 2023-09-19 | ↗ |
| 4 | Mindset Capital LLC | 14.81M | 8.68% | 14.81M | — | 14.81M | — | IA | DE | 2023-09-19 | ↗ |
| 5 | Catalyst Fund LP | 13.47M | 8.60% | 13.47M | — | 13.47M | — | PN | Delaware | 2022-01-26 | ↗ |
| 6 | Cassina | 12.07M | 39.86% | — | — | — | — | IN | : | 2010-05-13 | ↗ |
| 7 | Gerald Hickson | 8.50M | 8.38% | 8.50M | — | 8.50M | — | IN | United States | 2013-01-29 | ↗ |
| 8 | Mindset Value Fund LP | 7.76M | 4.55% | — | 7.76M | — | — | PN | DE | 2023-09-19 | ↗ |
| 9 | Mindset Value Wellness Fund LP | 7.05M | 4.13% | — | 7.05M | — | — | PN | DE | 2023-09-19 | ↗ |
| 10 | J. Hall | 6.10M | 23.10% | — | — | — | — | IN | : | 2009-12-11 | ↗ |
| 11 | JAMES CASSINA | 5.17M | 19.46% | 2.38M | — | — | — | IN | Canada | 2016-03-08 | ↗ |
| 12 | 1407271 | 4.40M | 17.00% | — | — | — | — | CO | : | 2009-12-11 | ↗ |
| 13 | Energy Enterprise, Inc. | 4.07M | 15.50% | — | — | — | — | CO | : | 2010-05-13 | ↗ |
| 14 | alan d. gaines | 4.00M | 10.07% | 4.00M | — | 4.00M | — | IN | United States | 2012-02-14 | ↗ |
| 15 | Adam S. Gottbetter | 2.17M | 9.00% | 2.17M | — | — | — | IN | Delaware | 2010-07-01 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | AdvisorShares Pure US Cannabis ETF MSOS | 0.13% | 1.18M | 0.81% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
8
Sells
0
Shares acquired
749.7K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+749,700
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-29 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 97,500 | 0.42 | 41.0K | 15,625,529 | I | ↗ |
| 2025-09-16 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 50,000 | 0.43 | 21.5K | 15,528,029 | I | ↗ |
| 2025-08-21 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 75,000 | 0.44 | 32.9K | 15,478,029 | I | ↗ |
| 2025-08-20 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 50,000 | 0.44 | 21.8K | 15,403,029 | I | ↗ |
| 2025-08-18 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 24,500 | 0.45 | 11.0K | 15,353,029 | I | ↗ |
| 2025-08-13 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 287,000 | 0.45 | 128.9K | 15,328,529 | I | ↗ |
| 2025-07-07 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 100,000 | 0.34 | 33.7K | 15,041,529 | I | ↗ |
| 2025-07-02 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 65,700 | 0.36 | 23.7K | 14,941,529 | I | ↗ |
| 2025-06-24 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 349,500 | 0.32 | 111.8K | 14,884,329 | I | ↗ |
| 2025-06-12 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 50,000 | 0.35 | 17.3K | 14,534,829 | I | ↗ |
| 2025-06-11 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 57,775 | 0.35 | 20.0K | 14,484,829 | I | ↗ |
| 2025-06-10 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 39,000 | 0.34 | 13.4K | 14,427,054 | I | ↗ |
| 2025-06-09 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 10,500 | 0.34 | 3.6K | 14,388,054 | I | ↗ |
| 2025-06-06 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 28,500 | 0.34 | 9.8K | 14,377,554 | I | ↗ |
| 2025-05-30 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 68,000 | 0.34 | 23.0K | 14,349,054 | I | ↗ |
| 2025-04-09 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 100,000 | 0.35 | 35.0K | 14,281,054 | I | ↗ |
| 2025-04-08 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 150,000 | 0.35 | 52.5K | 14,181,054 | I | ↗ |
| 2025-04-07 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 75,000 | 0.35 | 26.3K | 14,031,054 | I | ↗ |
| 2025-04-04 | Mindset Value Fund LP | 10% Owner | C-Conversion | A | Common Stock | 100,000 | 0.35 | 35.2K | 17,717,083 | I | ↗ |
| 2025-04-03 | Mindset Value Fund LP | 10% Owner | C-Conversion | A | Common Stock | 50,000 | 0.38 | 18.8K | 17,617,083 | I | ↗ |
| 2025-04-02 | Mindset Value Fund LP | 10% Owner | C-Conversion | A | Common Stock | 115,612 | 0.39 | 45.1K | 17,567,083 | I | ↗ |
| 2025-04-01 | Mindset Value Fund LP | 10% Owner | C-Conversion | A | Common Stock | 100,000 | 0.39 | 39.0K | 17,451,471 | I | ↗ |
| 2025-03-14 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 2,900 | 0.51 | 1.5K | 13,956,054 | I | ↗ |
| 2025-01-31 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 85,000 | 0.59 | 50.2K | 13,953,154 | I | ↗ |
| 2025-01-30 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 25,000 | 0.59 | 14.8K | 13,868,154 | I | ↗ |
| 2025-01-28 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 50,000 | 0.60 | 30.0K | 13,843,154 | I | ↗ |
| 2025-01-27 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 64,000 | 0.60 | 38.1K | 13,793,154 | I | ↗ |
| 2025-01-07 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 25,000 | 0.63 | 15.9K | 13,729,154 | I | ↗ |
| 2025-01-02 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 75,000 | 0.64 | 48.0K | 13,704,154 | I | ↗ |
| 2024-12-31 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 75,000 | 0.64 | 48.0K | 13,629,154 | I | ↗ |
| 2024-12-30 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 112,787 | 0.64 | 72.2K | 13,554,154 | I | ↗ |
| 2024-12-27 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 23,200 | 0.65 | 15.1K | 13,441,367 | I | ↗ |
| 2024-12-18 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 9,485 | 0.64 | 6.1K | 13,418,167 | I | ↗ |
| 2024-12-17 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 6,219 | 0.64 | 4.0K | 13,408,682 | I | ↗ |
| 2024-12-16 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 1,750 | 0.64 | 1.1K | 13,402,463 | I | ↗ |
| 2024-12-12 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 250,000 | 0.64 | 160.0K | 13,400,713 | I | ↗ |
| 2024-12-10 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 18,000 | 0.67 | 12.1K | 13,150,713 | I | ↗ |
| 2024-12-03 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 9,200 | 0.67 | 6.2K | 13,132,713 | I | ↗ |
| 2024-12-02 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 150,000 | 0.67 | 100.5K | 13,123,513 | I | ↗ |
| 2024-11-29 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 14,320 | 0.67 | 9.6K | 12,973,513 | I | ↗ |
| 2024-11-27 | Mindset Value Wellness Fund LP | 10% Owner | C-Conversion | A | Common Stock | 51,000 | 0.66 | 33.7K | 12,959,193 | I | ↗ |
| 2024-06-11 | Mindset Value Fund LP | 10% Owner | C-Conversion | A | Common Stock | 4,488,846 | 0.24 | 1.08M | 17,351,471 | — | ↗ |
| 2024-03-25 | Mindset Value Fund LP | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 26,258,303 | — | ↗ |
| 2022-04-08 | Tolia Sanjay | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 24,365,000 | — | ↗ |
| 2022-04-08 | Rosen Joshua | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 24,365,000 | — | ↗ |
| 2022-04-08 | Bengal Impact Partners, LLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 24,365,000 | — | ↗ |
| 2022-04-08 | BENGAL CATALYST FUND LP | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 24,365,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
16.6K
Shares Outstanding
249.94M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| J. Obie Strickler | President, Chief Executive Officer & Chairman | 500.0K | male |
| Nolan Snyder | National Director of Sales | 268.6K | — |
| David Pleitner | Manager of Golden Harvests | 262.1K | male |
| Andrew Marchington | Chief Financial Officer & Corporate Secretary | 252.9K | male |
| Jakob Iotte | Director of Business Development & IR | — | — |
| Joshua Nathaniel Rosen | Chief Strategy Officer | — | male |
| Kala Bernhardt | Corporate Controller | — | female |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GRUSF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
